Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma
Clinical trial NCT06321562 · TERMINATED
Trial details
- NCT number
- NCT06321562
- Sponsor
- EyeD Pharma
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-06-26
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.